| Literature DB >> 8169988 |
D M Ridley1, F Dawkins, E Perlin.
Abstract
The fact that a plasma factor was responsible for the stimulation of red cell production has been known for more than 35 years. However, it is only recently that the gene responsible for its production and its molecular structure has been identified. Furthermore, recombinant human erythropoietin is now available for clinical use. This article details the molecular biology and clinical pharmacology of this remarkable growth factor.Entities:
Mesh:
Substances:
Year: 1994 PMID: 8169988 PMCID: PMC2568173
Source DB: PubMed Journal: J Natl Med Assoc ISSN: 0027-9684 Impact factor: 1.798